National Evaluation of the DP18-1815 Cooperative Agreement Program: Category B, Cardiovascular Disease Prevention and Management

ICR 202003-0920-010

OMB: 0920-1311

Federal Form Document

Forms and Documents
Document
Name
Status
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Form and Instruction
New
Supplementary Document
2020-05-05
Supplementary Document
2020-05-05
Supplementary Document
2020-05-05
Supplementary Document
2020-05-05
Supplementary Document
2020-12-02
Supplementary Document
2020-05-05
Supplementary Document
2020-05-05
Supplementary Document
2020-05-05
Supplementary Document
2020-05-05
Supplementary Document
2020-05-05
Supplementary Document
2020-05-05
Supplementary Document
2020-05-05
Supplementary Document
2020-05-05
Supplementary Document
2020-05-05
Supplementary Document
2020-05-05
Supplementary Document
2020-05-05
Supporting Statement B
2020-12-02
Supporting Statement A
2020-12-02
ICR Details
0920-1311 202003-0920-010
Active
HHS/CDC 0920-20HP
National Evaluation of the DP18-1815 Cooperative Agreement Program: Category B, Cardiovascular Disease Prevention and Management
New collection (Request for a new OMB Control Number)   No
Regular
Approved with change 12/03/2020
Retrieve Notice of Action (NOA) 05/15/2020
  Inventory as of this Action Requested Previously Approved
12/31/2023 36 Months From Approved
253 0 0
743 0 0
30,515 0 0

The cooperative agreement, Improving the Health of Americans Through Prevention and Management of Diabetes and Heart Disease and Stroke, supports state investments in implementing and evaluating evidence-based strategies to prevent and manage diabetes and cardiovascular disease (CVD). This information collection request focuses on activities conducted under cooperative agreement Category B: Cardiovascular Disease (CVD) Prevention and Management. The purpose of data collection is to evaluate how states are using CDC DP18-1815 funds to implement evidence-based strategies, and determine how those efforts are contributing to state, health system, or other organization level changes/outcomes related to CVD.

US Code: 42 USC 241 Name of Law: Public Health Service Act
  
None

Not associated with rulemaking

  84 FR 32185 07/05/2019
85 FR 29451 05/15/2020
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 253 0 0 253 0 0
Annual Time Burden (Hours) 743 0 0 743 0 0
Annual Cost Burden (Dollars) 30,515 0 0 30,515 0 0
Yes
Miscellaneous Actions
No
This is a new information collection request.

$1,041,626
Yes Part B of Supporting Statement
    Yes
    No
No
No
No
No
Renita Macaluso 770 488-6458 arp5@cdc.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
05/15/2020


© 2024 OMB.report | Privacy Policy